China’s $1.5 Trillion Pile of Bad Debt Attracts Foreign Funds

Published 05/02/2020, 21:00
Updated 05/02/2020, 22:56
China’s $1.5 Trillion Pile of Bad Debt Attracts Foreign Funds

(Bloomberg) -- Sign up for Next China, a weekly email on where the nation stands now and where it's going next.

China’s massive pile of soured debt is set to get even bigger, giving foreign investors more opportunities to try to profit from the cleanup.

Nonperforming loans and stressed assets are likely to keep growing after reaching $1.5 trillion in 2019, according to a new study from PricewaterhouseCoopers.

The mountain of soured borrowings is rising as the world’s second-largest economy opens further to foreign capital. As part of a recent trade deal, China is now allowing U.S. firms to apply for licenses to buy non-performing loans directly from banks.

While the PwC report didn’t discuss the new coronavirus, other observers say the epidemic may add to credit strains. Read more about how the illness threatens a broader wave of defaults here.

That could further increase the need for distressed debt specialists to expand operations in China.

The contagion could “wreck havoc” in certain areas of the economy and there will probably be a substantial increase in distressed debt unless the central bank injects liquidity, according to Oaktree Capital Group LLC’s co-chairman. China’s beleaguered banks could take a $800 billion hit as the sickness threatens large swaths of the economy, S&P Global said.

Read about Goldman Sachs’ view that Chinese policymakers may adopt a forbearance stance

Borrowing costs for Chinese firms have increased recently due in part to the virus concerns, and that could make it more expensive for weaker companies to refinance obligations coming due soon.

China’s actual amount of bad loans has often been a source of debate. PwC’s measure is a broader one that includes NPLs, as well as loans on bank watch lists and NPLs held by asset management firms.

Official Chinese figures show that Chinese banks had 2.2 trillion yuan ($314 billion) of nonperforming loans reported as of the end of June.

‘Huge’ Market

However you slice it, the nation’s growing pool of soured debt is becoming harder to ignore.

“The size of the distressed market is huge,” said James Dilley, partner at PwC in an interview. “If you’re a distressed debt fund sitting in Boston, sitting in New York, sitting in London, the market is just so big it’s difficult to justify to LPs why you’re not looking at China.”

PwC estimates that international investors made $1.1 billion of investments into NPLs in 2019, and a number of high profile investors have been “screening deals and will be looking to close their first transaction in 2020.” Most of the deals done by foreign investors in the current cycle have been in China’s richest regions including Jiangsu, Zhejiang and Guangdong, according to PwC.

Anecdotally, there have been concerns about returns, and this is likely due to disappointing results on a handful of deals closed by foreign investors between 2015 and 2017, according to PwC.

Some investors were “naive” when it came to the time needed to recover individual loans, which affected returns, while the reduction in domestic liquidity since mid-2018 has made it tougher for some to on-sell their loans to local investors, the consultancy firm added.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.